(Q42395722)

29 October 2017

Using monoamine oxidase type B inhibitors in Parkinson's disease (English)

1 reference

Kailash Phatechand Bhatia

29 October 2017

1 reference

series ordinal

2

object named as

Kailash Bhatia

1 reference

29 October 2017

Yoav Ben-Shlomo

1

1 reference

PMC publication ID

516644

29 October 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

29 October 2017

1 reference

29 October 2017

329

1 reference

29 October 2017

7466

1 reference

29 October 2017

581-582

1 reference

Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients

29 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516644

Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516644

Treatment interventions for Parkinson's disease: an evidence based assessment

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516644

Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential i

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516644

Bias in meta-analysis detected by a simple, graphical test

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516644

Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516644

Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology?

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516644

Ten-year follow-up of three different initial treatments in de-novo PD: a randomized trial

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=516644

MAO-B inhibitors for the treatment of Parkinson's disease

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15361418

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Mortality in DATATOP: a multicenter trial in early Parkinson's disease. Parkinson Study Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15361418

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.329.7466.581

1 reference

29 October 2017

1 reference

PMC publication ID

516644

29 October 2017

PubMed publication ID

15361418

1 reference

PMC publication ID

516644